[64Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans

10Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Purpose: The aim of this study was to assess and compare the arterial uptake of the inflammatory macrophage targeting PET tracer [64Cu]Cu-DOTATATE in patients with no or known cardiovascular disease (CVD) to investigate potential differences in uptake. Methods: Seventy-nine patients who had undergone [64Cu]Cu-DOTATATE PET/CT imaging for neuroendocrine neoplasm disease were retrospectively allocated to three groups: controls with no known CVD risk factors (n = 22), patients with CVD risk factors (n = 24), or patients with known ischemic CVD (n = 33). Both maximum, mean of max and most-diseased segment (mds) standardized uptake value (SUV) and target-to-background ratio (TBR) uptake metrics were measured and reported for the carotid arteries and the aorta. To assess reproducibility between different reviewers, Bland–Altman plots were made. Results: For the carotid arteries, SUVmax (P =.03), SUVmds (0.05), TBRmax (P

Cite

CITATION STYLE

APA

Jensen, J. K., Madsen, J. S., Jensen, M. E. K., Kjaer, A., & Ripa, R. S. (2023). [64Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans. Journal of Nuclear Cardiology, 30(3), 986–1000. https://doi.org/10.1007/s12350-022-03084-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free